DCTH | Delcath Systems, Inc.

Index- P/E- EPS (ttm)-3.91 Insider Own1.50% Shs Outstand10.62M Perf Week11.17%
Market Cap82.78M Forward P/E- EPS next Y-0.89 Insider Trans187.83% Shs Float8.39M Perf Month37.48%
Income-37.30M PEG- EPS next Q-0.51 Inst Own18.90% Short Float / Ratio5.45% / 9.40 Perf Quarter64.46%
Sales2.90M P/S28.55 EPS this Y-14.70% Inst Trans-3.39% Short Interest0.46M Perf Half Y184.29%
Book/sh-1.13 P/B- EPS next Y52.20% ROA-166.30% Target Price16.40 Perf Year74.56%
Cash/sh2.33 P/C3.42 EPS next 5Y15.00% ROE552.10% 52W Range2.34 - 7.91 Perf YTD121.11%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High0.63% Beta0.83
Dividend %- Quick Ratio2.00 Sales past 5Y0.00% Gross Margin71.70% 52W Low240.17% ATR0.29
Employees52 Current Ratio2.20 Sales Q/Q50.00% Oper. Margin- RSI (14)87.26 Volatility3.52% 4.73%
OptionableYes Debt/Eq- EPS Q/Q29.50% Profit Margin- Rel Volume1.59 Prev Close7.80
ShortableYes LT Debt/Eq- EarningsMay 12 BMO Payout- Avg Volume48.65K Price7.96
Recom1.60 SMA2021.13% SMA5033.71% SMA20086.48% Volume76,521 Change2.05%
Date Action Analyst Rating Change Price Target Change
Jul-26-22Resumed Canaccord Genuity Buy $17
Dec-10-21Initiated H.C. Wainwright Buy $25
Mar-09-21Initiated Canaccord Genuity Buy $24
Jan-05-21Initiated BTIG Research Buy $23
Jun-01-20Initiated Laidlaw Buy $19
May-12-23 08:00AM
May-09-23 09:00AM
May-03-23 08:30AM
Apr-03-23 04:30PM
Mar-29-23 09:41PM
03:15PM Loading…
Mar-27-23 03:15PM
Feb-16-23 08:30AM
Feb-14-23 08:49AM
Jan-30-23 08:30AM
Jan-17-23 08:00AM
Dec-16-22 04:15PM
Dec-13-22 08:30AM
08:30AM Loading…
Dec-08-22 08:30AM
Dec-05-22 09:00AM
Nov-09-22 04:15PM
Nov-08-22 08:00AM
Oct-24-22 04:05PM
Sep-01-22 04:15PM
Aug-08-22 07:45AM
Aug-05-22 08:30AM
Jul-27-22 04:30PM
Jul-20-22 04:10PM
Jul-18-22 08:30AM
Jun-07-22 07:06AM
Jun-06-22 04:15PM
May-10-22 07:30AM
08:30AM Loading…
May-09-22 08:30AM
May-02-22 03:02PM
Apr-28-22 09:00AM
Apr-08-22 09:00AM
Mar-29-22 09:00AM
Mar-25-22 07:30AM
Mar-15-22 04:30PM
Mar-10-22 09:00AM
Mar-02-22 04:01PM
Feb-22-22 09:00AM
Feb-10-22 04:30PM
Feb-07-22 04:01PM
Feb-04-22 09:00AM
Feb-03-22 04:30PM
Jan-25-22 04:01PM
Jan-07-22 09:00AM
Dec-02-21 08:00AM
Nov-30-21 08:30AM
Nov-11-21 06:06AM
Nov-09-21 07:30AM
Nov-08-21 12:49PM
Nov-05-21 09:00AM
Nov-02-21 03:02PM
Oct-25-21 04:01PM
Sep-02-21 09:00AM
Aug-10-21 07:30AM
Aug-09-21 07:30AM
Aug-05-21 09:00AM
Aug-03-21 03:00PM
Jul-28-21 09:00AM
Jul-08-21 11:20AM
Jul-07-21 09:00AM
Jun-23-21 09:35AM
Jun-08-21 09:00AM
Jun-07-21 12:21PM
Jun-03-21 09:00AM
May-26-21 09:00AM
May-24-21 06:17AM
May-11-21 08:00AM
May-03-21 02:33AM
Apr-30-21 04:01PM
Apr-21-21 08:38AM
Mar-31-21 02:55PM
Mar-24-21 04:01PM
Mar-08-21 09:00AM
Feb-11-21 09:00AM
Jan-11-21 10:56AM
Dec-11-20 10:31AM
Dec-09-20 08:00AM
Dec-08-20 04:01PM
Dec-07-20 07:30AM
Nov-11-20 08:00AM
Nov-02-20 04:01PM
Oct-29-20 07:30AM
Oct-01-20 04:07PM
Sep-28-20 10:50AM
Sep-10-20 09:00AM
Sep-02-20 05:36PM
Aug-25-20 04:01PM
Aug-13-20 04:01PM
Aug-06-20 04:01PM
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MICHEL GERARD JChief Executive OfficerMar 29Buy4.8419,64695,087197,235Mar 30 09:00 AM
Rosalind Advisors, Inc.DirectorDec 14Buy3.6215,21555,045459,315Dec 16 09:32 AM
SALAMON STEVEN A JDirectorDec 14Buy3.6215,21555,045455,315Dec 16 09:22 AM
MICHEL GERARD JChief Executive OfficerDec 13Buy2.9051,725150,002177,589Dec 14 03:33 PM
MICHEL GERARD JChief Executive OfficerJul 20Buy3.9862,814250,000125,864Jul 21 10:29 AM